查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药物安全检测:市场占有率，规模，趋势，产业分析报告-各类服务，产品生命週期，各类型，流程，各治疗领域，各最终用途，各地区，市场区隔预测(2022～2030年)
市场调查报告书
商品编码
1078387

药物安全检测:市场占有率，规模，趋势，产业分析报告-各类服务，产品生命週期，各类型，流程，各治疗领域，各最终用途，各地区，市场区隔预测(2022～2030年)

Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球药物安全检测的市场规模到2030年前将达到158亿4,000万美元。

本报告提供全球药物安全检测市场相关调查分析，提供市场动态，波特的五力分析，服务供应商·产品生命週期·治疗领域·流程·类型·最终用途·各地区市场分析，竞争情形，企业简介等相关资讯。

目录

第1章 简介

  • 报告的说明
    • 调查的目的
    • 市场范围
    • 假设
  • 利害关係者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资料来源
    • 第一手资料
    • 第二手资料

第4章 全球药物安全检测市场洞察

  • 产业概述
  • 市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力(中)
    • 新加入厂商者的威胁(低)
    • 买方议价能力(中)
    • 替代威胁(中)
    • 现有企业间的竞争(高)
  • 大环境分析
  • 药物安全检测产业趋势
  • COVID-19影响分析

第5章 全球药物安全检测市场:各服务供应商

  • 主要调查结果
  • 简介
    • 各服务供应商:2018～2030年(10亿美元)
  • 内部
    • 各内部，各地区:2018～2030年(10亿美元)
  • 契约外包
    • 各契约外包，各地区:2018～2030年(10亿美元)

第6章 全球药物安全检测市场:各产品生命週期

  • 主要调查结果
  • 简介
    • 各产品生命週期:2018～2030年(10亿美元)
  • 前临床
    • 各前临床，各地区:2018～2030年(10亿美元)
  • 阶段I
    • 各阶段I，各地区:2018～2030年(10亿美元)
  • 阶段II
    • 各阶段II，各地区:2018～2030年(10亿美元)
  • 阶段III
    • 各阶段III，各地区:2018～2030年(10亿美元)
  • 阶段IV
    • 各阶段IV，各地区:2018～2030年(10亿美元)

第7章 全球药物安全检测市场:各治疗领域

  • 主要调查结果
  • 简介
    • 各类型:2018～2030年(10亿美元)
  • 肿瘤学
    • 各肿瘤学，各地区:2018～2030年(10亿美元)
  • 神经学
    • 神经学，各地区:2018～2030年(10亿美元)
  • 心臟病
    • 心臟病，各地区:2018～2030年(10亿美元)
  • 呼吸系统
    • 各呼吸系统，各地区:2018～2030年(10亿美元)
  • 其他
    • 其他，各地区:2018～2030年(10亿美元)

第8章 全球药物安全检测市场:各流程

  • 主要调查结果
  • 简介
    • 各流程:2018～2030年(10亿美元)
  • 案例资料管理
    • 各案例资料管理，各地区:2018～2030年(10亿美元)
    • 案例测井
    • 案例资料分析
    • 医学检讨和报告
  • 信号检测
    • 各信号检测，各地区:2018～2030年(10亿美元)
    • 不利事件的记录
    • 不利事件的分析
    • 不利事件检讨和报告
  • 风险管理系统
    • 风险管理各系统，各地区:2018～2030年(10亿美元)
    • 风险评估系统
    • 减少风险系统

第9章 全球药物安全检测市场:各类型

  • 主要调查结果
  • 简介
    • 各类型:2018～2030年(10亿美元)
  • 自发报告
    • 自发报告，各地区:2018～2030年(10亿美元)
  • 强化ADR报告
    • 强化ADR报告，各地区:2018～2030年(10亿美元)
  • 有针对性的自发性的报告
    • 有针对性的自发报告，各地区:2018～2030年(10亿美元)
  • 队列事件监控
    • 队列事件监控，各地区:2018～2030年(10亿美元)
  • EHR挖掘
    • EHR挖掘，各地区:2018～2030年(10亿美元)

第10章 全球药物安全检测市场:各最终用途

  • 主要调查结果
  • 简介
    • 各最终用途:2018～2030年(10亿美元)
  • 医药品
    • 各类医药品，各地区:2018～2030年(10亿美元)
  • 生物科技企业
    • 生物科技各企业，各地区:2018～2030年(10亿美元)
  • 医疗设备厂商
    • 医疗设备各製造厂商，各地区:2018～2030年(10亿美元)
  • 其他
    • 其他的各最终用途，各地区:2018～2030年(10亿美元)

第11章 全球药物安全检测市场:各地区

  • 主要调查结果
  • 简介
    • 各地区:2018～2030年(10亿美元)
  • 北美
    • 北美:各服务供应商-2018～2030年(10亿美元)
    • 各北美:流程-2018～2030年(10亿美元)
    • 各北美:产品生命週期-2018～2030年(10亿美元)
    • 北美:各类型-2018～2030年(10亿美元)
    • 北美:各治疗领域-2018～2030年(10亿美元)
    • 北美:各最终用途-2018～2030年(10亿美元)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各服务供应商-2018～2030年(10亿美元)
    • 各欧洲:流程-2018～2030年(10亿美元)
    • 各欧洲:产品生命週期-2018～2030年(10亿美元)
    • 欧洲:各类型-2018～2030年(10亿美元)
    • 欧洲:各治疗领域-2018～2030年(10亿美元)
    • 欧洲:各最终用途-2018～2030年(10亿美元)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区:各服务供应商-2018～2030年(10亿美元)
    • 各亚太地区:流程-2018～2030年(10亿美元)
    • 各亚太地区:产品生命週期-2018～2030年(10亿美元)
    • 亚太地区:各类型-2018～2030年(10亿美元)
    • 亚太地区:各治疗领域-2018～2030年(10亿美元)
    • 亚太地区:各最终用途-2018～2030年(10亿美元)
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 中东·非洲
    • 中东·非洲:各服务供应商-2018～2030年(10亿美元)
    • 各中东·非洲:流程-2018～2030年(10亿美元)
    • 各中东·非洲:产品生命週期-2018～2030年(10亿美元)
    • 中东·非洲:各类型-2018～2030年(10亿美元)
    • 中东·非洲:各治疗领域-2018～2030年(10亿美元)
    • 中东·非洲:各最终用途-2018～2030年(10亿美元)
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
  • 南美
    • 南美:各服务供应商-2018～2030年(10亿美元)
    • 各南美:流程-2018～2030年(10亿美元)
    • 各南美:产品生命週期-2018～2030年(10亿美元)
    • 南美:各类型-2018～2030年(10亿美元)
    • 南美:各治疗领域-2018～2030年(10亿美元)
    • 南美:各最终用途-2018～2030年(10亿美元)
    • 墨西哥
    • 巴西
    • 阿根廷

第12章 竞争情形

  • 扩大及收购分析
    • 扩大
    • 收购
  • 伙伴关係/合作/契约/展示会

第13章 企业简介

  • Accenture
  • ArisGlobal
  • BioClinica, Inc
  • Capgemini
  • Clinquest Group B.V. (Linical Americas)
  • Cognizant
  • FMD K&L
  • IBM Corporation
  • ICON Plc.
  • IQVIA
  • ITClinical
  • Laboratory Corporation of America Holdings
  • Linical Accelovance
  • PAREXEL International Corporation
  • TAKE Solutions
  • United BioSource Corporation
  • Wipro Limited
Product Code: PM2355

The global pharmacovigilance market size is expected to reach USD 15.84 Billion by 2030 according to a new study by Polaris Market Research. The report "Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The primary drivers of the market include rising medication intake novel drug development frequencies, rising prices of negative drug responses and drug toxicities, as well as an expanding tendency of contracting pharmacovigilance solutions is expected to boost the industry growth. Moreover, the pharmaceutical sector's excessive expenditure, rising incidence of adverse drug events, and drug mistakes are propelling the industry forward. Furthermore, the coronavirus pandemic has produced an emergency demand for a vaccine that has offered several chances for industry participants.

The contract outsources segment is expected to hold the major shares in the global market during the forecast period due to its benefits such as transforming fixed supply costs into variables, refining on-demand contact to distinctive expertise along with other benefits.

North America is expected to hold the major share in the global market over the forecast period due to increasing investment by the industry players in introducing novel drugs. Moreover, stringent regulations along with the presence of advanced healthcare systems in countries like the U.S. and Canada are expected to create lucrative opportunities for industry growth.

Some of the major players operating in the global market are ArisGlobal, Accenture, BioClinica, Inc., United BioSource Corporation, Clinquest Group B.V. (Linical Americas), Cognizant, Capgemini, FMD K&L, IBM Corporation, IQVIA, ICON Plc., ITClinical, Linical Accelovance, PAREXEL International Corporation, Laboratory Corporation of America Holdings, TAKE Solutions, and Wipro Limited.

Polaris Market Research has segmented the pharmacovigilance market report on the basis of service provider, product life cycle, type, process flow, therapeutic area, end-use, and region:

Pharmacovigilance, Service Provider Outlook (Revenue - USD Billion, 2018 - 2030)

In-house

Contract Outsourcing

Pharmacovigilance, Product Life Cycle Outlook (Revenue - USD Billion, 2018 - 2030)

Pre-clinical

Phase I

Phase II

Phase III

Phase IV

Pharmacovigilance, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Pharmacovigilance, Process Flow Outlook (Revenue - USD Billion, 2018 - 2030)

Case Data Management

Case Logging

Case Data Analysis

Medical Reviewing & Reporting

Signal Detection

Adverse Event Logging

Adverse Event Analysis

Adverse Event Review & Reporting

Risk Management System

Risk Evaluation System

Risk Mitigation System

Pharmacovigilance, Therapeutic Area Outlook (Revenue - USD Billion, 2018 - 2030)

Oncology

Neurology

Cardiology

Respiratory Systems

Others

Pharmacovigilance, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Pharmaceuticals

Biotechnology Companies

Medical Device Manufacturers

Others

Pharmacovigilance, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

Italy

France

Netherlands

Russia

Spain

Asia Pacific

China

Japan

India

Indonesia

Malaysia

South Korea

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Israel

Saudi Arabia

South Africa

UAE

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pharmacovigilance Market Insights

  • 4.1. Pharmacovigilance - Industry Snapshot
  • 4.2. Pharmacovigilance Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising prevalence of chronic disease
      • 4.2.1.2. Increasing investment in drug development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Issues related to data management
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Pharmacovigilance Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Pharmacovigilance Market, by Service Provider

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • 5.3. In-house
    • 5.3.1. Global Pharmacovigilance Market, by In-house, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Pharmacovigilance Market, by Contract Outsourcing, by Region, 2018 - 2030 (USD Billion)

6. Global Pharmacovigilance Market, by Product Life Cycle

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • 6.3. Pre-clinical
    • 6.3.1. Global Pharmacovigilance Market, by Pre-clinical, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Phase I
    • 6.4.1. Global Pharmacovigilance Market, by Phase I, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Phase II
    • 6.5.1. Global Pharmacovigilance Market, by Phase II, by Region, 2018 - 2030 (USD Billion)
  • 6.6. Phase III
    • 6.6.1. Global Pharmacovigilance Market, by Phase III, by Region, 2018 - 2030 (USD Billion)
  • 6.7. Phase IV
    • 6.7.1. Global Pharmacovigilance Market, by Phase IV, by Region, 2018 - 2030 (USD Billion)

7. Global Pharmacovigilance Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Pharmacovigilance Market, by Oncology, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Neurology
    • 7.4.1. Global Pharmacovigilance Market, by Neurology, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Cardiology
    • 7.5.1. Global Pharmacovigilance Market, by Cardiology, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Respiratory Systems
    • 7.6.1. Global Pharmacovigilance Market, by Respiratory Systems, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Other Pharmacovigilance Market, by Region, 2018 - 2030 (USD Billion)

8. Global Pharmacovigilance Market, by Process Flow

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • 8.3. Case Data Management
    • 8.3.1. Global Pharmacovigilance Market, by Case Data Management, by Region, 2018 - 2030 (USD Billion)
    • 8.3.2. Case Logging
      • 8.3.2.1. Global Pharmacovigilance Market, by Case Logging, by Region, 2018 - 2030 (USD Billion)
    • 8.3.3. Case Data Analysis
      • 8.3.3.1. Global Pharmacovigilance Market, by Case Data Analysis, by Region, 2018 - 2030 (USD Billion)
    • 8.3.4. Medical Reviewing & Reporting
      • 8.3.4.1. Global Pharmacovigilance Market, by Medical Reviewing & Reporting, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Signal Detection
    • 8.4.1. Global Pharmacovigilance Market, by Signal Detection, by Region, 2018 - 2030 (USD Billion)
    • 8.4.2. Adverse Event Logging
      • 8.4.2.1. Global Pharmacovigilance Market, by Adverse Event Logging, by Region, 2018 - 2030 (USD Billion)
    • 8.4.3. Adverse Event Analysis
      • 8.4.3.1. Global Pharmacovigilance Market, by Adverse Event Analysis, by Region, 2018 - 2030 (USD Billion)
    • 8.4.4. Adverse Event Review & Reporting
      • 8.4.4.1. Global Pharmacovigilance Market, by Adverse Event Review & Reporting, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Risk Management System
    • 8.5.1. Global Pharmacovigilance Market, by Risk Management System, by Region, 2018 - 2030 (USD Billion)
    • 8.5.2. Risk Evaluation System
      • 8.5.2.1. Global Pharmacovigilance Market, by Risk Evaluation System, by Region, 2018 - 2030 (USD Billion)
    • 8.5.3. Risk Mitigation System
      • 8.5.3.1. Global Pharmacovigilance Market, by Risk Mitigation System, by Region, 2018 - 2030 (USD Billion)

9. Global Pharmacovigilance Market, by Type

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • 9.3. Spontaneous Reporting
    • 9.3.1. Global Pharmacovigilance Market, by Spontaneous Reporting, by Region, 2018 - 2030 (USD Billion)
  • 9.4. Intensified ADR Reporting
    • 9.4.1. Global Pharmacovigilance Market, by Intensified ADR Reporting, by Region, 2018 - 2030 (USD Billion)
  • 9.5. Targeted Spontaneous Reporting
    • 9.5.1. Global Pharmacovigilance Market, by Targeted Spontaneous Reporting, by Region, 2018 - 2030 (USD Billion)
  • 9.6. Cohort Event Monitoring
    • 9.6.1. Global Pharmacovigilance Market, by Cohort Event Monitoring, by Region, 2018 - 2030 (USD Billion)
  • 9.7. EHR Mining
    • 9.7.1. Global Pharmacovigilance Market, by EHR Mining, by Region, 2018 - 2030 (USD Billion)

10. Global Pharmacovigilance Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 10.3. Pharmaceuticals
    • 10.3.1. Global Pharmacovigilance Market, by Pharmaceuticals, by Region, 2018 - 2030 (USD Billion)
  • 10.4. Biotechnology Companies
    • 10.4.1. Global Pharmacovigilance Market, by Biotechnology Companies, by Region, 2018 - 2030 (USD Billion)
  • 10.5. Medical Device Manufacturers
    • 10.5.1. Global Pharmacovigilance Market, by Medical Device Manufacturers, by Region, 2018 - 2030 (USD Billion)
  • 10.6. Others
    • 10.6.1. Global Other End-Uses Pharmacovigilance Market, by Region, 2018 - 2030 (USD Billion)

11. Global Pharmacovigilance Market, by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Pharmacovigilance Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 11.3. Pharmacovigilance Market - North America
    • 11.3.1. North America: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.3.2. North America: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.3.3. North America: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.3.4. North America: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.3.5. North America: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.3.6. North America: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.3.7. Pharmacovigilance Market - U.S.
      • 11.3.7.1. U.S.: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.3.7.2. U.S.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.3.7.3. U.S.: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.3.7.4. U.S.: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.3.7.5. U.S.: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.3.7.6. U.S.: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.3.8. Pharmacovigilance Market - Canada
      • 11.3.8.1. Canada: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.3.8.2. Canada.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.3.8.3. Canada: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.3.8.4. Canada: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.3.8.5. Canada: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.3.8.6. Canada: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.4. Pharmacovigilance Market - Europe
    • 11.4.1. Europe: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.4.2. Europe.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.4.3. Europe: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.4.4. Europe: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.4.5. Europe: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.4.6. Europe: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.7. Pharmacovigilance Market - UK
      • 11.4.7.1. UK: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.7.2. UK.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.7.3. UK: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.7.4. UK: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.7.5. UK: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.7.6. UK: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.8. Pharmacovigilance Market - France
      • 11.4.8.1. France: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.8.2. France.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.8.3. France: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.8.4. France: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.8.5. France: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.8.6. France: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.9. Pharmacovigilance Market - Germany
      • 11.4.9.1. Germany: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.9.2. Germany.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.9.3. Germany: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.9.4. Germany: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.9.5. Germany: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.9.6. Germany: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.10. Pharmacovigilance Market - Italy
      • 11.4.10.1. Italy: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.10.2. Italy.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.10.3. Italy: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.10.4. Italy: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.10.5. Italy: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.10.6. Italy: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.11. Pharmacovigilance Market - Spain
      • 11.4.11.1. Spain: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.11.2. Spain.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.11.3. Spain: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.11.4. Spain: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.11.5. Spain: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.11.6. Spain: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.12. Pharmacovigilance Market - Netherlands
      • 11.4.12.1. Netherlands: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.12.2. Netherlands.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.12.3. Netherlands: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.12.4. Netherlands: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.12.5. Netherlands: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.12.6. Netherlands: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.4.13. Pharmacovigilance Market - Russia
      • 11.4.13.1. Russia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.4.13.2. Russia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.4.13.3. Russia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.4.13.4. Russia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.4.13.5. Russia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.4.13.6. Russia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.5. Pharmacovigilance Market - Asia Pacific
    • 11.5.1. Asia Pacific: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.5.2. Asia Pacific.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.5.3. Asia Pacific: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.5.4. Asia Pacific: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.5.5. Asia Pacific: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.5.6. Asia Pacific: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.7. Pharmacovigilance Market - China
      • 11.5.7.1. China: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.7.2. China.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.7.3. China: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.7.4. China: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.7.5. China: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.7.6. China: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.8. Pharmacovigilance Market - India
      • 11.5.8.1. India: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.8.2. India.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.8.3. India: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.8.4. India: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.8.5. India: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.8.6. India: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.9. Pharmacovigilance Market - Japan
      • 11.5.9.1. Japan: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.9.2. Japan.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.9.3. Japan: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.9.4. Japan: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.9.5. Japan: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.9.6. Japan: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.10. Pharmacovigilance Market - Malaysia
      • 11.5.10.1. Malaysia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.10.2. Malaysia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.10.3. Malaysia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.10.4. Malaysia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.10.5. Malaysia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.10.6. Malaysia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.11. Pharmacovigilance Market - Indonesia
      • 11.5.11.1. Indonesia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.11.2. Indonesia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.11.3. Indonesia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.11.4. Indonesia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.11.5. Indonesia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.11.6. Indonesia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.5.12. Pharmacovigilance Market - South Korea
      • 11.5.12.1. South Korea: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.5.12.2. South Korea.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.5.12.3. South Korea: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.5.12.4. South Korea: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.5.12.5. South Korea: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.5.12.6. South Korea: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.6. Pharmacovigilance Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.6.2. Middle East & Africa: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.6.3. Middle East & Africa: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.6.4. Middle East & Africa: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.6.5. Middle East & Africa: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.6.6. Middle East & Africa: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.7. Pharmacovigilance Market - Saudi Arabia
      • 11.6.7.1. Saudi Arabia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.7.2. Saudi Arabia.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.7.3. Saudi Arabia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.7.4. Saudi Arabia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.7.5. Saudi Arabia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.7.6. Saudi Arabia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.8. Pharmacovigilance Market - UAE
      • 11.6.8.1. UAE: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.8.2. UAE.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.8.3. UAE: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.8.4. UAE: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.8.5. UAE: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.8.6. UAE: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.9. Pharmacovigilance Market - Israel
      • 11.6.9.1. Israel: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.9.2. Israel.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.9.3. Israel: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.9.4. Israel: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.9.5. Israel: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.9.6. Israel: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.6.10. Pharmacovigilance Market - South Africa
      • 11.6.10.1. South Africa: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.6.10.2. South Africa.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.6.10.3. South Africa: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.6.10.4. South Africa: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.6.10.5. South Africa: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.6.10.6. South Africa: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • 11.7. Pharmacovigilance Market - Latin America
    • 11.7.1. Latin America: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
    • 11.7.2. Latin America.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
    • 11.7.3. Latin America: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
    • 11.7.4. Latin America: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
    • 11.7.5. Latin America: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
    • 11.7.6. Latin America: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.7.7. Pharmacovigilance Market - Mexico
      • 11.7.7.1. Mexico: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.7.7.2. Mexico.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.7.7.3. Mexico: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.7.7.4. Mexico: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.7.7.5. Mexico: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.7.7.6. Mexico: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.7.8. Pharmacovigilance Market - Brazil
      • 11.7.8.1. Brazil: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.7.8.2. Brazil.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.7.8.3. Brazil: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.7.8.4. Brazil: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.7.8.5. Brazil: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.7.8.6. Brazil: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
    • 11.7.9. Pharmacovigilance Market - Argentina
      • 11.7.9.1. Argentina: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
      • 11.7.9.2. Argentina.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
      • 11.7.9.3. Argentina: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
      • 11.7.9.4. Argentina: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
      • 11.7.9.5. Argentina: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
      • 11.7.9.6. Argentina: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
    • 12.1.2. Acquisitions
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Accenture
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. ArisGlobal
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. BioClinica, Inc
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. Capgemini
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Clinquest Group B.V. (Linical Americas)
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Cognizant
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. FMD K&L
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. IBM Corporation
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. ICON Plc.
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. IQVIA
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development
  • 13.11. ITClinical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Benchmarking
    • 13.11.4. Recent Development
  • 13.12. Laboratory Corporation of America Holdings
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Benchmarking
    • 13.12.4. Recent Development
  • 13.13. Linical Accelovance
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Benchmarking
    • 13.13.4. Recent Development
  • 13.14. PAREXEL International Corporation
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Benchmarking
    • 13.14.4. Recent Development
  • 13.15. TAKE Solutions
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Benchmarking
    • 13.15.4. Recent Development
  • 13.16. United BioSource Corporation
    • 13.16.1. Company Overview
    • 13.16.2. Financial Performance
    • 13.16.3. Product Benchmarking
    • 13.16.4. Recent Development
  • 13.17. Wipro Limited
    • 13.17.1. Company Overview
    • 13.17.2. Financial Performance
    • 13.17.3. Product Benchmarking
    • 13.17.4. Recent Development

List of Tables

  • Table 1 Global Pharmacovigilance Market, by Service Provider, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Pharmacovigilance Market, by Process Flow, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Pharmacovigilance Market, by Product Life Cycle, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Pharmacovigilance Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Pharmacovigilance Market, by Therapeutic Area, by Region, 2018 - 2030 (USD Billion)
  • Table 6 Global Pharmacovigilance Market, by End-Use, by Region, 2018 - 2030 (USD Billion)
  • Table 7 Pharmacovigilance Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 8 North America: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 9 North America: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 10 North America: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 11 North America: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 12 North America: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 13 North America: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 14 U.S.: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 15 U.S.: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 16 U.S.: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 17 U.S.: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 18 U.S.: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 19 U.S.: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 20 Canada: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 21 Canada: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 22 Canada: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 23 Canada: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 24 Canada: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 25 Canada: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 26 Europe: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 27 Europe: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 28 Europe: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 29 Europe: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 30 Europe: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 31 Europe: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 32 UK: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 33 UK: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 34 UK: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 35 UK: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 26 UK: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 37 UK: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 38 France: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 39 France: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 40 France: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 41 France: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 42 France: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 43 France: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 44 Germany: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 45 Germany: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 46 Germany: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 47 Germany: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 48 Germany: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 49 Germany: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 50 Italy: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 51 Italy: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 52 Italy: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 53 Italy: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 54 Italy: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 55 Italy: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 56 Spain: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 57 Spain: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 58 Spain: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 59 Spain: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 60 Spain: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 61 Spain: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 62 Netherlands: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 63 Netherlands: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 64 Netherlands: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 65 Netherlands: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 66 Netherlands: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 67 Netherlands: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 68 Russia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 69 Russia: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 70 Russia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 71 Russia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 72 Russia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 73 Russia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 74 Asia Pacific: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 75 Asia Pacific: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 76 Asia Pacific: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 77 Asia Pacific: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 78 Asia Pacific: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 79 Asia Pacific: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 80 China: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 81 China: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 82 China: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 83 China: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 84 China: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 85 China: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 86 India: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 87 India: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 88 India: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 89 India: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 90 India: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 91 India: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 92 Japan: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 93 Japan: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 94 Japan: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 95 Japan: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 96 Japan: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 97 Japan: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 98 Malaysia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 99 Malaysia: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 100 Malaysia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 101 Malaysia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 102 Malaysia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 103 Malaysia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 104 Indonesia: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 105 Indonesia: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 106 Indonesia: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 107 Indonesia: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 108 Indonesia: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 109 Indonesia: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 110 South Korea: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 111 South Korea: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)
  • Table 112 South Korea: Pharmacovigilance Market, by Product Life Cycle, 2018 - 2030 (USD Billion)
  • Table 113 South Korea: Pharmacovigilance Market, by Type, 2018 - 2030 (USD Billion)
  • Table 114 South Korea: Pharmacovigilance Market, by Therapeutic Area, 2018 - 2030 (USD Billion)
  • Table 115 South Korea: Pharmacovigilance Market, by End-Use, 2018 - 2030 (USD Billion)
  • Table 116 Middle East & Africa: Pharmacovigilance Market, by Service Provider, 2018 - 2030 (USD Billion)
  • Table 117 Middle East & Africa: Pharmacovigilance Market, by Process Flow, 2018 - 2030 (USD Billion)